← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2011Last known activity
Feb 1, 2022
Timeline
2010s
- Jan 1, 2011
Samyang Biopharmaceuticals Corporation— Founded
Drugs by trial phase (18 distinct, 21 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Hyperlipidemias
- Lung Neoplasms
- Lymphoma
- Mycoses
- Neoplasms
- Neuralgia
- Neuralgia, Postherpetic
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Peripheral Nerve Injuries
- Squamous Cell Carcinoma of Head and Neck
- Urinary Bladder Neoplasms
Recent trials (22)
- NCT05207514Lead sponsorPhase 3Feb 1, 2022
- NCT04627753CollaboratorPhase 2Nov 2, 2020
- NCT03674060Lead sponsorPhase 1Oct 31, 2018
- NCT02982395Lead sponsorPhase 3Dec 1, 2016
- NCT03208218Lead sponsorPhase 1Aug 17, 2016
- NCT02739529Lead sponsorPhase 1Apr 1, 2016
- NCT02739633Lead sponsorPhase 2Apr 1, 2016
- NCT02639858Lead sponsorPhase 2Oct 1, 2015
- NCT02263495CollaboratorPhase 2Nov 1, 2014
- NCT02274610Lead sponsorPhase 1Nov 1, 2014
- NCT02274610Study directorPhase 1Nov 1, 2014
- NCT01657201Lead sponsorPhase 1Sep 1, 2012
- NCT01504984Lead sponsorPhase 1Mar 1, 2012
- NCT01353404Lead sponsorPhase 1Jun 1, 2011
- NCT01103791Lead sponsorPhase 1Apr 1, 2010
Details
- Founded
- Seoul, KR Jan 1, 2011
- Last known activity
- Feb 1, 2022